Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis

Exclusion Criteria

• •1. Treated with these medications before including in the study
• •* Topical corticosteroid for scalp psoriasis (except emollients and shampoo) within 2 weeks
• •* Very potent topical corticosteroids for psoriasis on other area or Narrow band Ultraviolet B (NB-UVB) within 2 weeks
• •* Oral psoralen plus Ultraviolet A (PUVA) or oral medication (Methotrexate, Acitretin, Cyclosporine) within 4 weeks
• •* Biologic agents or concomitant medication that could affect scalp psoriasis (Beta- blockers, Antimalarial drugs, Lithium ) within 6 months
• •2. Has skin infection or atrophic skin on the scalp
• •3. Has history of allergic reaction or hypersensitivity to 0.25% Desoximetasone
• •4. Female participants with pregnancy or in lactation period
• •5. Participants who unable to come for follow-up visits at hospital
• •6. Participants with other underlying disease e.g. diabetes mellitus, hypertension, thyroid disease
• •7. Vulnerable subject e.g. illiterate person